The leading global healthcare company Abbott is to construct a new greenfield manufacturing facility in Kilkenny and further invest in its Donegal Diabetes Care site, representing a combined investment of €440 million and creating 1,000 jobs between the two sites.
The project is supported by the Irish Government through IDA Ireland.
The new 250,000 sq. ft. state-of-the-art manufacturing facility, which will be located on the IDA Business and Technology Park in Loughboy, Kilkenny, subject to planning permission, will give Abbott the capacity to substantially increase production of its FreeStyle Libre technology for people with diabetes.
Speaking about today’s announcement, Taoiseach Micheal Martin said: “This new investment by Abbott in Donegal and Kilkenny is hugely welcome news, bringing up to 1,000 highly-skilled jobs and expanded Medtech manufacturing capacity.